ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1638

Synovial Fibroblast Migration Is Modulated by the Focal Contact Protein Lasp-1

Adelheid Korb-Pap1, Jan Hillen1, Marianne Heitzmann1, Catherine S. Chew2, Stefan Butz3, Dietmar Vestweber4, Hermann Pavenstädt5 and Thomas Pap1, 1Institute of Experimental Muskuloskeletal Medicine, University Hospital Muenster, Muenster, Germany, 2Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, 3Max Planck Institute of Molecular Biomedicine, Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 4Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 5Internal Medicine D, Department of Nephrology and Rheumatology, University Hospital Muenster, Muenster, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, cartilage, fibroblasts and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: RA synovial fibroblasts (SF) have been suggested to contribute to the spreading of disease through their ability to leave cartilage destruction sites, migrate via the bloodstream and re-initiate the destructive process at distant articular cartilage surfaces. The underlying mechanisms are unclear, but the actin-crosslinking protein Lasp-1 is of interest in this context, because it localizes to the leading edges of migrating cells and is of importance for the metastatic dissemination of different tumors. Therefore, it is particularly important to investigate the role of Lasp-1 in synovial fibroblast migration and its effects on RA.

Methods: The expression of Lasp-1 in the hind paws of wt and hTNFtg mice, an established model for human RA, was investigated by immunohistochemistry. Western-blot analyses and immunofluorescence was performed to analyze Lasp-1 expression and sub-cellular distribution in SFs from wt and hTNFtg mice. The migratory capacity of SFs derived from wild-type, Lasp-1-/-and hTNFtg mice was studied in a modified scratch assay as well as in a transmigration assay using murine endothelioma cells (bEnd.5) as an endothelial barrier and TNF-alpha as a stimulus. Furthermore, we used Lasp-1 knockout mice for interbreeding studies with hTNFtg mice.

Results:  Immunostainings and Western Blot analyses showed a prominent expression of Lasp-1 in synovial fibroblasts obtained from hTNFtg mice with a characteristic sub-cellular distribution localizing Lasp-1 to structures of cell adhesion and invasion. In the scratch assay, Lasp-1-/- SFs exhibited a significantly reduced migration rate after 2 days (-30% vs. wt, p<0.05). Although the migratory capacity of unstimulated wt SFs through the endothelial monolayer was generally low (-32% vs. hTNFtg, p<0.05), this was virtually abolished by the knock out of Lasp-1 (-78% vs. wt, p<0.05). TNF-alpha enhanced the migratory potential of wild-type SFs to a significantly higher extent than of Lasp-1 null SFs (+84%, p<0.05). Interestingly, interbred Lasp1-/-/hTNFtg mice presented milder clinical symptoms and analyses of histopathology revealed less cartilage degradation than hTNFtg mice at an age of 14 weeks. 

Conclusion: Our data provide first evidence that Lasp-1 regulates the migratory capacity of synovial fibroblasts and influences the severity of arthritis in hTNFtg mice. While the mechanisms of trans-endothelial migration of SFs are largely undiscovered, our data suggest that these cells – when activated – migrate through the formation of invasive and adhesive membrane structures such as invadopodia, where Lasp-1 is prominently localized. Thus, targeting Lasp-1 may be a promising strategy modulate the invasive and migratory behavior of synovial fibroblasts in RA.


Disclosure:

A. Korb-Pap,
None;

J. Hillen,
None;

M. Heitzmann,
None;

C. S. Chew,
None;

S. Butz,
None;

D. Vestweber,
None;

H. Pavenstädt,
None;

T. Pap,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fibroblast-migration-is-modulated-by-the-focal-contact-protein-lasp-1/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology